Freenome, Inc. Common stock (FRNM) Stock Price

FRNMStock

$13.99

Market Cap$1.50B

P/E1519.45x

PEG Ratio—

Div yield—

Beta0.05

FRNM Share Price Chart

Favorite Metrics

Price vs S&P 500 (4W)24.90%

VGM Score45.05

P/E Ratio (Annual)1519.45x

FRNM Earnings Surprise History

Q2 26-2.59est. —

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
FRNMFreenome, Inc. Common stock	—	F	A	$13.99
NTRANatera, Inc. Common Stock	F	A	A	$336.71
LHLabcorp Holdings Inc.	C	D	B	$337.68
DGXQuest Diagnostics Inc.	C	D	B	$244.51
GHGuardant Health, Inc. Common Stock	F	A	A	$164.92
CAICaris Life Sciences, Inc. Common Stock	F	A	B	$28.01
RDNTRadNet, Inc. Common Stock	D	C	C	$76.86
BLLNBillionToOne, Inc. Class A Common Stock	F	F	C	$100.08
CELCCelcuity Inc. Common Stock	—	—	D	$92.27
GRALGRAIL, Inc. Common Stock	D	A	B	$82.54
VCYTVeracyte, Inc.	D	A	C	$44.04
CDNACareDx, Inc.	D	B	A	$50.80
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.25
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.27
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	B	$12.07
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$35.00
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.95
YDESYD Bio Limited Ordinary Shares	—	—	D	$4.68
BDSXBiodesix, Inc. Common Stock	D	B	A	$28.07
XGNExagen Inc. Common Stock	D	B	B	$7.60
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$9.80
SERASera Prognostics, Inc. Class A Common Stock	D	D	C	$2.18
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.79
ADVBAdvanced Biomed Inc. Common Stock	A	—	B	$9.18
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	D	$2.49
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	D	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.36

About Freenome, Inc. Common stock

Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.